Javier Delgado

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

Mi Kwon, Gloria Iacoboni, Juan Luis Reguera et al. · Haematologica · 2022 · 132 citations · Full text

Medicine, Hematology, Oncology +13

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy

Gloria Iacoboni, Josu Iraola‐Truchuelo, Maeve O’Reilly et al. · HemaSphere · 2024 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO

Rebeca Bailén, Gloria Iacoboni, Javier Delgado et al. · Transplantation and Cellular Therapy · 2024 · 18 citations

Life Sciences, Immunology, Oncology +14

Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy

Gloria Iacoboni, Josu Iraola‐Truchuelo, Alberto Mussetti et al. · Blood · 2022 · 16 citations

Medicine, Hematology, Oncology +15

Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment

Gloria Iacoboni, Vı́ctor Navarro, Pierre Sesques et al. · Journal of Hematology & Oncology · 2024 · 14 citations · Full text

Medicine, Hematology, Oncology +17